Alternative Ways of Framing Parkinson's Disease: Implications for Priorities in Health Care and Biomedical Research

Abstract

American philosopher Donald Schön provided an account of profes sional problem solving, "reflection in action." An important compo nent of this is "framing experiments"—testing different ways of defin ing (framing) a problem by asking "Can I solve the problem thus set?" and "Would it result in a different solution?" Such questions are an swered by taking recourse to bodies of knowledge, theories, norms, and principles, which together constitute "overarching theories" and "appreciative systems." Such overarching theories and appreciative systems are quite specific for particular professional communities. In this article, Schön's theory is used to describe professional problem solving in a medical context by unraveling the contents of the over arching theories and appreciative systems of various medical subspe cialities. Thus Schön's theory is used to reveal the factors that determine to a large extent patient care and priorities in biomedical research and development. The existence of multiple, sometimes incompatible over arching theories and appreciative systems is used as an argument in favour of interactivity in technology assessment.

Get full access to this article

View all access options for this article.

References

Adams, S.G. , & Lang, A.E. (1992). Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? European Journal of Disorders in Communication, 27,121-127.

Agid, Y. , Taquet, H. , Cesselin, F. , Epelbaum, J. , & Javoy-Agid, F. (1986). Neuropeptides and Parkinson's disease In P. C. Emson, M. Rossor, & M. Tokyama (Eds.), Peptides and neurological disease (pp.107-116). Amsterdam: Elsevier.

Alves, R.S.C. , Barbosa, E.R. , & Scaff, M. (1992). Postvaccinal parkinsonism Movement Disorders, 7,178-180.

Armstrong, M. , Daly, A.K. , Cholerton, S. , Bateman, D.N. , & Idle, J.R. (1993). Mutant debrisoquine hydroxylation genes in Parkinson's disease The Lancet, 339, 1017-1018.

Askenasy, J.J. (1993). Sleep in Parkinson's disease Acta Neurologica Scandinavica, 87, 167-170.

Astarloa, M.A. , Sanchez, V. , de la Vega, L. , & de Yebenes, J.G. (1992). Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease Clinical Neuropharmacology, 15, 375-380.

Barbeau, A. , Roy, M. , Cloutier, T. , Plasse, L. , & Paris, S. (1986). Environmental and genetic factors in the etiology of Parkinson's disease Advances in Neurology , 45, 299-306.

Barker, R. (1991). Substance P and neurodegenerative disorders: A speculative review Neuropeptides, 20, 73-78.

Barolin, G.S. , & Hodkewitsch, E. , Jr. (1991). 10 Jahre nachgehender neurologischer Rehabilitationsdienst—Teil des "Rehabilitations modells Voralberg." Rehabilitation Stuttgart , 30, 18-22.

10.

Briley, M. (1993). Noradrenergic mechanisms in Parkinson's disease Trends in Pharmacological Sciences , 14, 33-40.

11.

Bunders, J.F.G., & Broerse, J.E.W. (Eds.). (1991). Appropriate biotechnology in small-scale agriculture: How to reorient research and development. Wallingford, UK: C.A.B. International.

12.

Burn, D.J. , Mark, M.H. , Playford, E.D. , Maraganore, D.M. , Zimmerman, T.R., Jr. , Duvoisin, R. , Harding, A.E. , & Marsden , C.D. (1992). Parkinson's disease in twins studied with 18F-DOPA and positron emission tomography Neurology, 42, 1894-1900.

13.

Calne, D.B. , & Langston, J.W. (1983). The aetiology of Parkinson's disease The Lancet, pp. 1457-1459.

14.

Coleman, R.E. , Briner, W.H. , & Siegel, B.A. (1992). Clinical PET scanning. A "short-lived" orphan International Journal of Technology Assessment in Health Care, 8, 610-622.

15.

Cooper, J.A. , Sagar, H.J. , Doherty, S.M. , Jordan, N. , Tidswell, P. , & Sullivan, E.V. (1992). Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease: A follow-up study of untreated patients Brain, 115, 1701-1725.

16.

Dawkins, R. (1976). The selfish gene Oxford: Oxford University Press.

17.

Durand-Zaleski, I. , Reizine, D. , Puzin, D. , Merland, J.J. , & Blum-Boisregard, C. (1993). Economic assessment of magnetic resonance imaging for in-patients: Is it still too early? International Journal of Technology Assessment in Health Care , 9, 263-273.

18.

Edwards, L. , Quigley, E.M. , Hofman, R. , & Pfeiffer, R.F. (1993). Gastrointestinal symptoms in Parkinson's disease: 18 months follow-up study Movement Disorders, 8, 83-86.

19.

Ekberg, O. , & Feinberg, M. (1992). Clinical and demographic data in 75 patients with near-fatal choking episodes Dysphagia , 7, 205-208.

20.

Fazzini, E. (1992). Transplantation in the treatment of paralysis agitans (Parkinson's disease Journal of the American Osteopathology Association, 92,1255-1260.

21.

Forno, L.S. (1990). Pathology of Parkinson's disease: The importance of the substantia nigra and Lewy bodies In G. M. Stem (Ed.), Parkinson's disease (pp. 185-238). London: Chapman & Hall.

22.

Freed, C.R., et al. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease The New England Journal of Medicine , 327,1549-1555.

23.

Godwin-Austen, R.B. (1990). Physical treatments In G. M. Stem (Ed.), Parkinson's disease (pp. 647-662). London: Chapman & Hall.

24.

Grossman, M. , Crino, P. , Reivich, M. , Stem, M.B. , & Hurtig, H.I. (1992). Attention and sentence processing deficits in Parkinson's disease: The role of anterior cingulate cortex Cerebral Cortex, 2, 513-525.

25.

Groves, A.K. , Barnett, S.C. , Franklin, R.J.M. , Crang, A.J. , Mayer, M. , Blakemore, W.F. , & Noble, M. (1993). Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells Nature , 362, 453-455.

26.

Guba, E.G. , & Lincoln, Y.S. (1989). Fourth generation evaluation London: Sage.

27.

Hesslow, G. (1984). What is a genetic disease? On the relative importance of causes In L. Nordenfelt & B.I.B. Lindahl (Eds.), Philosophy and medicine: Vol. 16. Health, disease, and causal explanations in medicine (pp. 183-193). Dordrecht: Reidel.

28.

Hughes, A.J. , Bishop, S. , Kleedorfer, B. , Turjanski, N. , Fernandez, W. , Lees, A.J. , & Stem, G.M. (1993). Subcutaneous apomorphine in Parkinson's disease: Response to chronic administration for up to five years Movement Disorders, 8,165-170.

29.

Kuhn, T.S. (1970). The structure of scientific revolutions (2nd ed., enlarged). Chicago: University of Chicago Press.

30.

Jenner, P. , Schapira, A.H.V. , & Marsden, C.D. (1992). New insights into the cause of Parkinson's disease Neurology, 42, 2241-2250.

31.

Johnson, W.G. , Hodge, S.E. , & Duvoisin, R. (1990). Twin studies and the genetics of Parkinson's disease—A reappraisal Movement Disorders , 5,187-194.

32.

Kohbata, S. , & Shimokawa, K. (1993). Circulating antibody to Nocardia in the serum of patients with Parkinson's disease Advances in Neurology , 60, 355-357.

33.

Kondo, I. , & Kanazawa, I. (1993). Debrisoquine hydroxylase and Parkinson's disease Advances in Neurology, 60, 338-342.

34.

Laitinen, L.V. , Bergenheim, A.T. , & Hariz, M.I. (1992). Ventropostreal pallidotomy can abolish all parkinsonian symptoms Stereotactic Functional Neurosurgery , 58,14-21.

35.

Langston, J.W. , Ballard, P. , Tetru, J.W. , & Irwin, I. (1983). Chronic parkinsonism in humans due to a product of mepiridine-analog synthesis Science , 219, 979-980.

36.

Larsen, J.P. , & Norwegian Study Group of Parkinson's Disease in the Elderly (1991). Parkinson's disease as community health problem: Study in Norwegian nursing homes British Medical Journal, 303 , 741-743.

37.

Lieberman, A. (1992). An integrated approach to patient management in Parkinson's disease Neurologic Clinics , 10, 553-665.

38.

Lin, L.F.H. , Doherty, D.H. , Lile, J.D. , Bektesh, S. , & Collins, F. (1993). A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science , 260, 1130-1132.

39.

Marsden, C.D. (1987). Parkinson's disease in twins Journal of Neurology, Neurosurgery and Psychiatry, 50, 105-106.

40.

Martilla, R.J. , Kaprio, J. , Koskenvuo, M.D. , & Rinne, U.K. (1988). Parkinson's disease in a nationwide twin cohort Neurology, 38, 217-219.

41.

Mazziotta, J.C. , Frackowiak, R.S. , Phelps, M.E. (1992). Seminars in Nuclear Medicine , 2, 233-246.

42.

Nora, K. , & Fraser, B. (1981). Medical genetics: Principles and practice (2nd ed.). Philadelphia : Lea & Febiger.

43.

Parkinson's disease: One illness or many syndromes? [Editorial]. ( 1992). The Lancet, 339,1263-1264.

44.

Pentland, B. , Barnes, M.P. , Findley, L.J. , Oxtoby, M. , Pearce, V.R. , Quinn, N.P. , & Scott, S. (1992). Parkinson's disease: The spectrum of disabilities Journal of Neurology, Neurosurgery and Psychiatry , 55(Suppl.), 32-35.

45.

Quinn, N.P. , & Daniel, S.E. (1993). Juvenile parkinsonism caused by chronic meningoencephalitis : A clinicopathological study Clinical Neuropathology , 12, 19-24.

46.

Rabey, J.M. , Vered, Y. , Shabtai, H. , Graff, E. , Harsat, A. , & Korczyn, A.D. (1993). Broad bean (Vicia faba) consumption and Parkinson's disease Advances in Neurology, 60, 881-884.

47.

Rybicki, B.A. , Johnson, C.C. , Uman, J. , & Gorell, J.M. (1993). Parkinson's disease, mortality and the industrial use of heavy metals in Michigan Movement Disorders , 8, 87-92.

48.

Sacks, O.W. (1990). Postencephalitic syndromes In G. M. Stem (Ed.), Parkinson's disease (pp. 415-429). London: Chapman & Hall.

49.

Sawle, G.V. , Wroe, S.J. , Lees, A.J. , Brooks, D.J. , & Frackowiak, R.S.J. (1992). The identification of presymptomatic parkinsonism: Clinical 18F-DOPA positron emission tomography studies in an Irish kindred Annals of Neurology , 32, 609-617.

50.

Schön, D.A. (1983). The reflective practitioner: How professionals think in action New York: Basic Books.

51.

Sechi, G.P. , Agnetti, V. , Piredda, M. , Canu, M. , Deserra, F. , Omar, H.A. , & Rosati, G. (1992). Acute and persistent parkinsonism after use of diquat Neurology, 42, 261-263.

52.

Shapira, O.M. , Mor, E. , & Pfefferman, R. (1992). Parkinson syndrome. Asignificant risk factor in the patient with acute surgical disorder International Surgery, 77 , 313-316.

53.

Smith, C. (1974). Concordance in twins: Methods and interpretation American Journal of Human Genetics , 26, 454-466.

54.

Snyder, S.H. , & D'Amato, R.J. (1985). Predicting Parkinson's disease Nature, 317, 198-199.

55.

Spencer, D.D., et al. (1992). Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease The New England Journal of Medicine , 327,1541-1548.

56.

Stenager, E.N. , & Stenager, E. (1992). Suicide and patients with neurologic diseases: Methodologic problems Archives in Neurology , 49,1296-1303.

57.

Todes, C. (1983, April 30). Inside parkinsonism: A psychiatrist's personal experience The Lancet, pp. 977-978.

58.

Velasco, F. , Velasco M. , Rodriguez-Cuevas, H. , Jurado, J. , Olvera, J. , & Jiminez, F. (1991). Autologous adrenal medullary transplants in advanced Parkinson's disease with particular attention to the selective improvement in symptoms Stereotactic Functional Neurosurgery , 57,195-212.

59.

Vieregge, R. , & Dethlefsen, J. (1992). Krankengymnastik und Logopaedie beim Parkinson-Sydrom—eine Bestandsaufnahme Fortschritte in Neurologie und Psychiatrie, 60, 369-374.

60.

Ward, C.D. , Duvoisin, R.C. , Ince, S.E. , Nutt, J.D. , Eldridge, R. , & Calne, D.B. (1983). Parkinson's disease in 65 pairs of twins and in a set of quadruplets Neurology, 33, 815-824.

61.

Widner, H., et al. (1992). Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP The New England Journal of Medicine , 327,1556-1563.